Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway

被引:41
作者
Ueoka, Y
Kato, K
Kuriaki, Y
Horiuchi, S
Terao, Y
Nishida, J
Ueno, H
Wake, N
机构
[1] Kyushu Univ, Med Inst Bioregulat, Dept Reprod Physiol & Endocrinol, Beppu, Oita 8740838, Japan
[2] Kyushu Univ, Dept Cardiol, Fukuoka 812, Japan
关键词
hepatocyte growth factor; motility; invasion; ovarian carcinoma; ras; MAP kinase;
D O I
10.1054/bjoc.1999.1016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocyte growth factor (HGF) is a multifunctional growth factor which has pleiotrophic biological effects on epithelial cells such as proliferation, motogenesis, invasiveness and morphogenesis. Peritoneal dissemination is critical for the progression of ovarian cancer, and our study revealed that HGF induces migration and invasion of ovarian cancer cells. We also demonstrated that HGF stimulates autophosphorylation of its receptor, followed by activation of the Pas-MAP (mitogen-activated peptide) kinase cascade. Moreover, infection of ovarian cancer cells with Ras dominant-negative adenovirus reduced the HGF-induced motogenic and invasive activities. Additionally both MEK and PI3-kinase pathways downstream of Ras were involved in HGF-stimulated ovarian cancer cell invasiveness. (C) 2000 Cancer Research Campaign.
引用
收藏
页码:891 / 899
页数:9
相关论文
共 23 条
  • [1] Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
    Boccaccio, C
    Andò, M
    Tamagnone, L
    Bardelli, A
    Michieli, P
    Battistini, C
    Comoglio, PM
    [J]. NATURE, 1998, 391 (6664) : 285 - 288
  • [2] Corps AN, 1997, INT J CANCER, V73, P151, DOI 10.1002/(SICI)1097-0215(19970926)73:1<151::AID-IJC23>3.0.CO
  • [3] 2-I
  • [4] OVEREXPRESSION OF THE MET HGF RECEPTOR IN OVARIAN-CANCER
    DIRENZO, MF
    OLIVERO, M
    KATSAROS, D
    CREPALDI, T
    GAGLIA, P
    ZOLA, P
    SISMONDI, P
    COMOGLIO, PM
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (05) : 658 - 662
  • [5] HARTMANN G, 1994, J BIOL CHEM, V269, P21936
  • [6] Jeffers M, 1996, ONCOGENE, V13, P853
  • [7] Jeffers M, 1996, MOL CELL BIOL, V16, P1115
  • [8] KOBAYASHI H, 1994, CANCER RES, V54, P261
  • [9] Lamszus K, 1998, INT J CANCER, V75, P19, DOI 10.1002/(SICI)1097-0215(19980105)75:1<19::AID-IJC4>3.0.CO
  • [10] 2-4